The IDEATE: IPILIMUMAB DRUG EVALUATION brand, founded in 2010 (United States), from 496 sister brands and 17478 competing brands. The IDEATE: IPILIMUMAB DRUG EVALUATION brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. IDEATE: IPILIMUMAB DRUG EVALUATION belongs to the Drug Manufacturers business sector.